Yuanyuan Cao

Novel pyridinone derivatives as non-nucleoside reverse transcriptase inhibitors (NNRTIs) with high potency against NNRTI-resistant HIV-1 strains.

Y. Shao, Shibo Jiang, Liying Ma, 2013, Journal of medicinal chemistry.

Dual inhibitors of ASK1 and PDK1 kinases: Design, synthesis, molecular docking and mechanism studies of N-benzyl pyridine-2-one containing derivatives as anti-fibrotic agents.

Qianbin Li, Gaoyun Hu, Yuanyuan Cao, 2022, European journal of medicinal chemistry.

Synthesis and biological evaluation of pyridinone analogues as novel potent HIV-1 NNRTIs.

Liying Ma, Ying Guo, Junyi Liu, 2015, Bioorganic & medicinal chemistry.

Synthesis and Biological Evaluation of Novel 2-Arylalkylthio-5-iodine-6-substituted-benzyl-pyrimidine-4(3H)-ones as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors

Xiaowei Wang, Chao Tian, Ying Guo, 2014, Molecules.

Multistep Virtual Screening Based Identification of Homeodomain-Interacting Protein Kinase 2 Inhibitors: An Opportunity for Treating Chronic Kidney Disease

Qianbin Li, Gaoyun Hu, Yuanyuan Cao, 2021, Chemometrics and Intelligent Laboratory Systems.

Pulmonary artery smooth muscle cell phenotypic switching: A key event in the early stage of pulmonary artery hypertension.

Qianbin Li, Gaoyun Hu, Yuanyuan Cao, 2023, Drug discovery today.

Curzerene suppresses progression of human glioblastoma through inhibition of glutathione S‐transferase A4

Dianshuai Gao, Yuanyuan Cao, Linfang Wang, 2022, CNS neuroscience & therapeutics.